WuXi AppTec Co Ltd

Common Name

WuXi AppTec

Country

China (Mainland)

Sector

Healthcare

Industry

Diagnostics & Research

Employees

37,832

Ticker

603259

Exchange

SHANGHAI STOCK EXCHANGE

Website

www.wuxiapptec.com

Description

WuXi AppTec Co., Ltd. is a leading biotechnology and pharmaceutical company. Its primary function is to provide contract research, development, and manufacturing services to pharmaceutical, biotechnol... Show more

Income Statement Balance Sheet

Financial Statements of WuXi AppTec

Below are the financial statements of WuXi AppTec, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

All figures in millions of CNY	2024	2023
Continuing operations	—	—
Revenue	37,917.78^a	38,678^a
Discontinued operations	—	—
Revenue	1,323.65^a	1,662.81^a
Total	—	—
Revenue	39,241.43^a	40,340.81^a
Cost of sales	-21,646.51^a	-22,421.64^a
Cost of sales	-1,578.8^a	-1,546.7^a
Cost of sales	-23,225.31^a	-23,968.34^a
Gross profit (loss)	16,271.27^a	16,256.36^a
Gross profit (loss)	-255.15^a	116.11^a
Gross profit (loss)	16,016.12^a	16,372.47^a
Other income	1,145.94^a	962.38^a
Other income	0.16^a	0.12^a
Other income	1,146.1^a	962.5^a
Other gains and losses	808.12^a	1,356.52^a
Other gains and losses	-3.68^a	-6.25^a
Other gains and losses	804.44^a	1,350.28^a
Impairment losses under expected credit losses (ECL) model, net of reversal	-325.3^a	-237.3^a
Impairment losses under expected credit losses (ECL) model, net of reversal	-9.02^a	-3.6^a
Impairment losses under expected credit losses (ECL) model, net of reversal	-334.32^a	-240.89^a
Impairment losses of non-financial assets	-115.58^a	-67.4^a
Impairment losses of non-financial assets	0^a	0^a
Impairment losses of non-financial assets	-115.58^a	-67.4^a
Impairment losses of goodwill	-110.43^a	-49.61^a
Impairment losses of goodwill	0^a	0^a
Impairment losses of goodwill	-110.43^a	-49.61^a
Impairment losses of assets classified as held for sale	0^a	0^a
Impairment losses of assets classified as held for sale	-948.41^a	0^a
Impairment losses of assets classified as held for sale	-948.41^a	0^a
Selling and marketing expenses	-638.17^a	-580.07^a
Selling and marketing expenses	-107.22^a	-120.96^a
Selling and marketing expenses	-745.39^a	-701.03^a
Administrative expenses	-2,577.14^a	-2,665.7^a
Administrative expenses	-432.34^a	-329.24^a
Administrative expenses	-3,009.48^a	-2,994.95^a
R&D expenses	-1,187.1^a	-1,361.01^a
R&D expenses	-51.42^a	-79.63^a
R&D expenses	-1,238.53^a	-1,440.63^a
Operating profit (loss)	13,271.61^a	13,614.19^a
Operating profit (loss)	-1,807.08^a	-423.45^a
Operating profit (loss)	11,464.53^a	13,190.74^a
Share of results of associates	252.14^a	-35.08^a
Share of results of associates	0^a	0^a
Share of results of associates	252.14^a	-35.08^a
Share of results of joint ventures	-7.07^a	-32.48^a
Share of results of joint ventures	0^a	0^a
Share of results of joint ventures	-7.07^a	-32.48^a
Finance costs	-236.14^a	-157.68^a
Finance costs	-32.43^a	-35.9^a
Finance costs	-268.57^a	-193.58^a
Profit (loss) before tax	13,280.54^a	13,388.95^a
Profit (loss) before tax	-1,839.51^a	-459.35^a
Profit (loss) before tax	11,441.03^a	12,929.6^a
Income tax expense	-1,982.49^a	-2,046.58^a
Income tax expense	-10.42^a	-85.15^a
Income tax expense	-1,972.07^a	-2,131.73^a
Profit (loss) for the year	11,298.05^a	11,342.37^a
Profit (loss) for the year	-1,829.09^a	-544.5^a
Profit (loss) for the year	9,468.96^a	10,797.87^a
Profit (loss) for the year attributable to owners of the company	—	—
From continuing operations	11,181.7^a	11,234.65^a
From discontinued operations	-1,829.09^a	-544.5^a
Profit for the year attributable to non-controlling interests	—	—
From continuing operations	116.35^a	107.72^a

Download Data

Verified Sources Behind WuXi AppTec’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore WuXi AppTec’s data sources below and access millions more through our Disclosure Search.

a. WuXi AppTec's Annual Report 2024

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

WuXi AppTec Co Ltd

Financial Statements of WuXi AppTec

Verified Sources Behind WuXi AppTec’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

WuXi Biologics (Cayman) Inc

Pharmaron Beijing Co Ltd

CSPC Pharmaceutical Group Ltd

Tasly Pharmaceutical Group Co Ltd

Zai Lab Ltd

Joincare Pharmaceutical Group Industry Co Ltd